483 related articles for article (PubMed ID: 25967138)
1. Latest approaches for the treatment of obesity.
Jackson VM; Breen DM; Fortin JP; Liou A; Kuzmiski JB; Loomis AK; Rives ML; Shah B; Carpino PA
Expert Opin Drug Discov; 2015; 10(8):825-39. PubMed ID: 25967138
[TBL] [Abstract][Full Text] [Related]
2. Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies.
Jackson VM; Price DA; Carpino PA
Expert Opin Investig Drugs; 2014 Aug; 23(8):1055-66. PubMed ID: 25000213
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for the treatment of obesity.
Martinussen C; Bojsen-Moller KN; Svane MS; Dejgaard TF; Madsbad S
Expert Opin Emerg Drugs; 2017 Mar; 22(1):87-99. PubMed ID: 27927032
[TBL] [Abstract][Full Text] [Related]
4. Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss.
Barja-Fernandez S; Leis R; Casanueva FF; Seoane LM
Drug Des Devel Ther; 2014; 8():2391-400. PubMed ID: 25489237
[TBL] [Abstract][Full Text] [Related]
5. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
[TBL] [Abstract][Full Text] [Related]
6. Anti-obesity drugs: a review about their effects and their safety.
Derosa G; Maffioli P
Expert Opin Drug Saf; 2012 May; 11(3):459-71. PubMed ID: 22439841
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years.
Rose F; Bloom S; Tan T
Expert Opin Drug Discov; 2019 Nov; 14(11):1151-1159. PubMed ID: 31355685
[No Abstract] [Full Text] [Related]
8. Novel strategy for the use of leptin for obesity therapy.
Tam CS; Lecoultre V; Ravussin E
Expert Opin Biol Ther; 2011 Dec; 11(12):1677-85. PubMed ID: 21910668
[TBL] [Abstract][Full Text] [Related]
9. New drug targets for the treatment of obesity.
Powell AG; Apovian CM; Aronne LJ
Clin Pharmacol Ther; 2011 Jul; 90(1):40-51. PubMed ID: 21654742
[TBL] [Abstract][Full Text] [Related]
10. Drug treatment of obesity in cardiovascular disease.
Charakida M; Finer N
Am J Cardiovasc Drugs; 2012 Apr; 12(2):93-104. PubMed ID: 22292446
[TBL] [Abstract][Full Text] [Related]
11. New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier?
Kennett GA; Clifton PG
Pharmacol Biochem Behav; 2010 Nov; 97(1):63-83. PubMed ID: 20688100
[TBL] [Abstract][Full Text] [Related]
12. Leptin signaling as a therapeutic target of obesity.
Sáinz N; González-Navarro CJ; Martínez JA; Moreno-Aliaga MJ
Expert Opin Ther Targets; 2015 Jul; 19(7):893-909. PubMed ID: 25726860
[TBL] [Abstract][Full Text] [Related]
13. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.
Verpeut JL; Bello NT
Expert Opin Drug Saf; 2014 Jun; 13(6):831-41. PubMed ID: 24766397
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon.
Srivastava G; Apovian C
Curr Obes Rep; 2018 Jun; 7(2):147-161. PubMed ID: 29504049
[TBL] [Abstract][Full Text] [Related]
16. Well-being of obese individuals: therapeutic perspectives.
Chaput JP; Tremblay A
Future Med Chem; 2010 Dec; 2(12):1729-33. PubMed ID: 21428796
[TBL] [Abstract][Full Text] [Related]
17. The role of pramlintide for weight loss.
Dunican KC; Adams NM; Desilets AR
Ann Pharmacother; 2010 Mar; 44(3):538-45. PubMed ID: 20164472
[TBL] [Abstract][Full Text] [Related]
18. Targeting thermogenesis and related pathways in anti-obesity drug discovery.
Clapham JC; Arch JR
Pharmacol Ther; 2011 Sep; 131(3):295-308. PubMed ID: 21514319
[TBL] [Abstract][Full Text] [Related]
19. Centrally Acting Agents for Obesity: Past, Present, and Future.
Coulter AA; Rebello CJ; Greenway FL
Drugs; 2018 Jul; 78(11):1113-1132. PubMed ID: 30014268
[TBL] [Abstract][Full Text] [Related]
20. The incretin pathway as a new therapeutic target for obesity.
Barber TM; Begbie H; Levy J
Maturitas; 2010 Nov; 67(3):197-202. PubMed ID: 20655673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
